@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 occursIn: species:10090; rdf:object schem:serum%20glucose; rdf:predicate belv:increases; rdf:subject schem:Advanced%20Glycation%20End%20Product; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"Advanced Glycation End Product\") -> a(SCHEM:\"serum glucose\")" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_3; pav:version "20131211" . sub:_2 prov:value "75% of HAGE-HF mice were diabetic and exhibited higher body weight (P< 0.001), fasting glucose (P < 0.001), insulin (P< 0.001), and serum AGEs (P < 0.01) than control mice, while none of the LAGE-HF mice were diabetic despite a similar rise in body weight and plasma lipids."; prov:wasQuotedFrom pubmed:16046296 . sub:_3 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:16046296; prov:wasDerivedFrom beldoc:, sub:_2 . } sub:pubinfo { this: dct:created "2014-07-03T14:32:48.090+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }